Blog
[printfriendly]
-
Oct 1, 2011
Cancer Researchers Study 'Scrambler Therapy' for Pain Relief
Researchers at University of Wisconsin Carbone Cancer Center are testing a new pain therapy device for patients with nerve pain following chemotherapy treatments. With 40 percent of chemotherapy patients developing… -
Oct 1, 2011
Colorectal Cancer Drug Linked with Nerve Damage
Oxaliplatin has become the standard of care for people with advanced colorectal cancer. It appears to cause nerve damage that may be permanent and worsens even months after treatment ends…. -
Sep 20, 2011
New Research has Potential to Alleviate Side Effects of Cancer Treatments
Beth Faiman MSN, CNP, a doctoral candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University, is studying whether an over-the-counter medication could ease chemotherapy side effects… -
Sep 12, 2011
Westover Vets Fight for Agent Orange Benefits
An Air Force reserve squadron out of Westover Air Force Base in Massachusetts, is finding some curious coincidences among the men who served with them. C-123 Provider planes used to… -
Sep 1, 2011
Scientists Find Gene that Controls Chronic Pain
Scientists at Cambridge University, London, have identified a gene responsible for regulating chronic pain. Their drug discovery should help drug researchers in their search for more effective, targeted pain-killing medicines…. -
Sep 1, 2011
NeurogesX Submits Supplemental new Drug Application for Qutenza (R) 8% Patch for HIV-Associated Peripheral Neuropathy
Biopharmaceutical company, NeurogesX, announced it submitted a supplemental new drug to the US FDA seeking to expand the label to include an application for the management of pain due to… -
Sep 1, 2011
Olive Leaf Extract May Help Fight Early-Diabetes Nerve Damage, Pain
At Kerman University of Medical Sciences in Kerman, Iran, researchers investigated the possible effects of olive leaf extract on in vitro and in vivo models of diabetic peripheral neuropathy. Their… -
Sep 1, 2011
U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage
Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by…